J Antimicrob Chemother 2012, 67:849–856 PubMedCrossRef 15

J Antimicrob Chemother 2012, 67:849–856.PubMedCrossRef 15. RG 7204 Capanna F, Emonet SP, Cherkaoui A, Irion OP, Schrenzel J, MartinezdeTejada B: Antibiotic resistance patterns among group B Streptococcus isolates: Implications for antibiotic prophylaxis for early-onset neonatal sepsis. Swiss Med Wkly 2013, 143:0. 16. Leclercq R: Mechanisms of resistance to macrolides and lincosamides: Nature of the resistance elements and their clinical implications. Clin Infect Dis 2002, 34:482–492.PubMedCrossRef 17. Clancy J, Petitpas J, Dib-Hajj F, Yuan W, Cronan M, Kamath AV, Bergeron J, Retsema

JA: Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA , from Streptococcus pyogenes . Mol Microbiol 1996, 22:867–879.PubMedCrossRef 18. Cieslewicz MJ, Chaffin D, Glusman G, Kasper D, Madan A, Rodrigues S, Fahey J, Wessels

MR, Rubens CE: Structural and genetic diversity of group B streptococcus capsular polysaccharides. Infect Immun 2005, 73:3096–3103.PubMedCentralPubMedCrossRef 19. Slotved HC, Kong F, Lambertsen L, Sauer S, Gilbert GL: Serotype Doxorubicin solubility dmso IX, a Proposed New Streptococcus agalactiae Serotype. J Clin Microbiol 2007, 45:2929–2936.PubMedCentralPubMedCrossRef 20. Murayama SY, Seki C, Sakata H, Sunaoshi K, Nakayama E, Iwata S, Sunakawa K, Ubukata K: Capsular type and antibiotic resistance in Streptococcus agalactiae isolates from patients, ranging from newborns to the elderly, with invasive infections. Antimicrob Agents Chemother 2009, 53:2650–2653.PubMedCentralPubMedCrossRef 21. Madzivhandila M, Adrian PV, Cutland CL, Kuwanda L, Madhi SA: Distribution of pilus islands of group B streptococcus associated with maternal colonization and invasive disease in South Africa. J Med Microbiol 2013, 62:249–253.PubMedCrossRef 22. Marques MB, Kasper DL, Pangburn MK, Wessels MR: Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci. Infect Immun 1992, 60:3986–3993.PubMedCentralPubMed 23. Lauer P, Rinaudo CD, Soriani M, Margarit I, Maione D, Rosini R, Taddei

AR, Mora M, Rappuoli R, Grandi G, Telford JL: Genome analysis reveals pili in Group B Streptococcus . Science 2005, 309:105.PubMedCrossRef 24. Sharma P, Lata H, Arya DK, Kashyap AK, Kumar H, Dua M, Amoxicillin Ali A, Johri AK: Role of pilus proteins in adherence and invasion of Streptococcus agalactiae to the lung and cervical epithelial cells. J Biol Chem 2013, 288:4023–4034.PubMedCrossRef 25. Rinaudo CD, Rosini R, Galeotti CL, Berti F, Necchi F, Reguzzi V, Ghezzo C, Telford JL, Grandi G, Maione D: Specific involvement of pilus type 2a in biofilm formation in group B Streptococcus . PLoS One 2010, 5:e9216.PubMedCentralPubMedCrossRef 26. Maisey HC, Quach D, Hensler ME, Liu GY, Gallo RL, Nizet V, Doran KS: A group B streptococcal pilus protein promotes phagocyte resistance and systemic virulence. FASEB J 2008, 22:1715–1724.

Comments are closed.